Link Pharma Chem Ltd received a demand order from the Assistant Commissioner of Vadodara, raising demand for GST, together with interest as applicable and penalty. The authority has started acting against the violations related to tax declaration mismatches and excess Input Tax Credit claims.
Discrepancy in tax declaration mismatch declared in GSTR1 and tax paid through GSTR3B. Excess IT claims on the import of goods are not reflected in GSTR-2A. Link Pharma Chem received the demand order on January 26, 2027, and has disclosed in compliance with SEBI regulations.
Statutory auditors CNK & Associates LLP were recommended by the Audit Committee before Board approval. The company manufactures and sells chemicals under a single business segment and maintains its paid-up equity share capital.
With appropriate authority, the pharmaceutical company intends to appeal the demand order. The company supplies products and services to several chemical and pharmaceutical companies, manufacturing and exporting a range of intermediates for pharmaceuticals, agro industries, and speciality chemicals.
Rishikesh Thakur, managing director, signed the communication with BSE Limited and stated to ensure transparency with stakeholders regarding the regulatory development.
Link Pharma Chem operates from its registered office in GIDC, Vadodara, Gujarat, and is engaged in pharmaceutical and chemical manufacturing activities. The promoter continues to focus on R&D to develop new molecules with its expert team and with developed technologies.
It has been able to carve a niche in the industry by using the right blend of Research strengths, Manufacturing capabilities, Human Resources, and a well-established quality management system. Modern multipurpose plant, necessary infrastructure, experienced and trained workforce are the contributing factors towards excellent quality consistency as per industry standards.